Back to School: How biopharma can reboot drug development. Access exclusive analysis here

AVI raises $20.3 million

AVII raised $20.3 million in a registered direct offering of 10.7

Read the full 113 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE